Oxygenator for use with extracorporeal support of premature fetus

US12268802B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12268802-B2
Application numberUS-202017603173-A
CountryUS
Kind codeB2
Filing dateApr 8, 2020
Priority dateApr 9, 2019
Publication dateApr 8, 2025
Grant dateApr 8, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are devices and methods directed to oxygenators for use in extracorporeal circuits for supporting a fetus. An oxygenator for use with an extracorporeal circuit includes a housing defining a cavity therein and a gas exchanger disposed within the interior cavity. The cavity is configured to receive blood a fetus. The gas exchanger is configured to receive a sweep gas and further configured to contact the blood within the cavity, such that at least oxygen gas and carbon dioxide gas is permitted to diffuse between the blood and the gas exchanger.

First claim

Opening claim text (preview).

What is claimed is: 1. An oxygenator for use with an extracorporeal circuit, the oxygenator comprising: a housing defining a cavity therein, the cavity being configured to receive blood from a fetus; and a gas exchanger disposed within the cavity, the gas exchanger being configured to receive a sweep gas and to contact the blood within the cavity, such that at least oxygen gas and carbon dioxide gas is permitted to diffuse between the blood and the gas exchanger, the gas exchanger including a plurality of fibers, wherein each fiber has a receiving end, an emitting end opposite the receiving end, and a channel extending between the receiving end and the emitting end, and wherein each fiber is configured to receive a sweep gas at the receiving end and pass the sweep gas through the channel and out of the emitting end wherein the gas exchanger is substantially cylindrical having two opposing end planes; the oxygenator has a direction of flow of blood through the gas exchanger; and wherein each of the plurality of fibers extends between the two opposing end planes and is arranged perpendicular to the direction of flow of blood. 2. The oxygenator of claim 1 , wherein the gas exchanger includes a first portion of the plurality of fibers, and wherein each of the first portion of the plurality of fibers are disposed parallel to each other in a first planar arrangement. 3. The oxygenator of claim 2 , wherein the gas exchanger includes a second portion of the plurality of fibers, wherein each of the second portion of the plurality of fibers are disposed parallel to each other in a second planar arrangement and perpendicular to the first portion of the plurality of fibers. 4. The oxygenator of claim 1 , wherein the oxygenator is devoid of a heating element therein to heat the blood flowing therethrough. 5. The oxygenator of claim 1 , wherein the plurality of fibers comprise polymethylpentene (PMP). 6. The oxygenator of claim 1 , wherein the oxygenator is pumpless, and the flow of blood is actuated by the fetus. 7. The oxygenator of claim 1 , further comprising a gas bleed port configured to release a predetermined amount of the sweep gas from the oxygenator. 8. The oxygenator of claim 1 , further comprising a blood inlet port configured to receive blood from the fetus into the oxygenator and a blood outlet port configured to discharge the blood from the oxygenator to the fetus. 9. The oxygenator of claim 8 , wherein the blood inlet port includes a pressure transducer configured to measure the pressure of the blood entering the oxygenator. 10. The oxygenator of claim 8 , further comprising a plurality of blood inlet ports. 11. The oxygenator of claim 8 , wherein the blood outlet port includes a pressure transducer configured to measure the pressure of the blood exiting the oxygenator. 12. The oxygenator of claim 1 , further comprising a gas inlet port configured to receive the sweep gas into the oxygenator, and a gas inlet sampling port configured to allow a portion of the sweep gas to be removed from the gas inlet port. 13. The oxygenator of claim 1 , further comprising a gas outlet port configured to emit the sweep gas out of the oxygenator, and a gas outlet sampling port configured to allow a portion of the sweep gas to be removed from the gas outlet port. 14. The oxygenator of claim 1 , wherein the oxygenator is configured to be primed with less than about 100 mL of a priming material. 15. The oxygenator of claim 14 , wherein the priming material comprises human blood. 16. The oxygenator of claim 1 , wherein the gas exchanger includes an anticoagulant coating. 17. The oxygenator of claim 1 , wherein the oxygenator is configured to maintain a desired functional range of the at least oxygen gas and carbon dioxide gas diffusion for at least 7 days. 18. An extracorporeal system for supporting a fetus, the system comprising: a chamber configured to receive the fetus; an oxygenator operatively connected to the fetus and configured to provide a gas exchange to blood from the fetus wherein the oxygenator has a priming volume between 20 mL and 50 mL, the oxygenator comprising a gas exchanger including a plurality of fibers, wherein the gas exchanger includes a first portion of the plurality of fibers, and wherein each of the first portion of the plurality of fibers are disposed parallel to each other in a first planar arrangement, and wherein the gas exchanger includes a second portion of the plurality of fibers, wherein each of the second portion of the plurality of fibers are disposed parallel to each other in a second planar arrangement, wherein each of the first portion of the plurality of fibers and the second portion of the plurality of fibers is arranged perpendicular to a direction of flow of blood within the gas exchanger; and a heating element configured to maintain a desired temperature of the system. 19. The extracorporeal system of claim 18 , wherein the heating element is separate from the oxygenator. 20. The extracorporeal system of claim 18 , wherein the oxygenator is configured to be removable from the system and replaced with another oxygenator. 21. The extracorporeal system of claim 18 wherein the oxygenator has a gas transfer rate of about 150 mL/min or greater of oxygen gas. 22. The extracorporeal system of claim 18 wherein the oxygenator is configured to be primed with less than about 100 mL of a priming material comprising human blood. 23. The extracorporeal system of claim 18 wherein the oxygenator is pumpless, and the flow of blood is actuated by the fetus. 24. An oxygenator for use with an extracorporeal circuit, the oxygenator comprising: a housing defining a cavity therein, the cavity being configured to receive blood from a fetus; and a gas exchanger disposed within the cavity, the gas exchanger being configured to receive a sweep gas and to contact the blood within the cavity, such that at least oxygen gas and carbon dioxide gas is permitted to diffuse between the blood and the gas exchanger, the gas exchanger including a plurality of fibers, wherein each fiber has a receiving end, an emitting end opposite the receiving end, and a channel extending between the receiving end and the emitting end, a first portion of the plurality being fibers disposed parallel to each other and in a first planar arrangement, a second portion of the plurality of fibers being fibers disposed parallel to each other and in a second planar arrangement, wherein the oxygenator defines a direction of flow of blood through the gas exchanger, and wherein each of the first portion of fibers and the second portion of fibers is arranged perpendicular to the direction of flow of blood.

Assignees

Inventors

Classifications

  • Means for actively controlling temperature of blood · CPC title

  • Specially adapted for neonatal use · CPC title

  • A61M1/3666Primary

    Cardiac or cardiopulmonary bypass, e.g. heart-lung machines · CPC title

  • Baby-incubators; Couveuses · CPC title

  • A61M1/1698Primary

    Blood oxygenators with or without heat-exchangers (intracorporal A61M1/1678; manufacturing of membranes therefor B01D67/00; semi-permeable membranes for separation processes characterised by their properties B01D69/00; semi-permeable membranes characterised by their material B01D71/00) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12268802B2 cover?
Disclosed are devices and methods directed to oxygenators for use in extracorporeal circuits for supporting a fetus. An oxygenator for use with an extracorporeal circuit includes a housing defining a cavity therein and a gas exchanger disposed within the interior cavity. The cavity is configured to receive blood a fetus. The gas exchanger is configured to receive a sweep gas and further configu…
Who is the assignee on this patent?
Childrens Hospital Philadelphia
What technology area does this patent fall under?
Primary CPC classification A61M1/3666. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).